Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65370-33-4

Post Buying Request

65370-33-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65370-33-4 Usage

Medicinal use

Treats type 2 diabetes.

Function

Increases insulin production and decreases glucose production by the liver.

Drug class

Dipeptidyl peptidase-4 (DPP-4) inhibitors.

Administration

Often prescribed in combination with diet and exercise.

Check Digit Verification of cas no

The CAS Registry Mumber 65370-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,7 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 65370-33:
(7*6)+(6*5)+(5*3)+(4*7)+(3*0)+(2*3)+(1*3)=124
124 % 10 = 4
So 65370-33-4 is a valid CAS Registry Number.

65370-33-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl (2S)-2-(1H-1,2,4-triazol-5-yl)pyrrolidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names (S)-Benzyl 2-(4H-1,2,4-triazol-3-yl)pyrrolidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65370-33-4 SDS

65370-33-4Downstream Products

65370-33-4Relevant articles and documents

Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers

Lloyd, John,Finlay, Heather J.,Vacarro, Wayne,Hyunh, Tram,Kover, Alexander,Bhandaru, Rao,Yan, Lin,Atwal, Karnail,Conder, Mary Lee,Jenkins-West, Tonya,Shi, Hong,Huang, Christine,Li, Danshi,Sun, Huabin,Levesque, Paul

scheme or table, p. 1436 - 1439 (2010/07/02)

Design and synthesis of pyrazolodihydropyrimidines as KV1.5 blockers led to the discovery of 7d as a potent and selective antagonist. This compound showed atrial selective prolongation of effective refractory period in rabbits and was selected for clinical development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65370-33-4